liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cancer stem cell markers in common cancers - therapeutic implications
Department of Human Anatomy and Cell Sciences, Winnipeg, Canada.
Manitoba Institute of Cell Biology, CancerCare Manitoba; Department of Human Genetics, University of Aarhus, Aarhus, Denmark.
Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, R3E 0W3, MB, Canada.
Manitoba Institute of Cell Biology, CancerCare Manitoba, Winnipeg, R3E 0V9, MB, Canada; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, R3E 0W3, MB, Canada.
Show others and affiliations
2008 (English)In: Trends in Molecular Medicine, ISSN 1471-4914, E-ISSN 1471-499X, Vol. 14, no 10, 450-460 p.Article, review/survey (Refereed) Published
Abstract [en]

Rapid advances in the cancer stem cell (CSC) field have provided cause for optimism for the development of more reliable cancer therapies in the future. Strategies aimed at efficient targeting of CSCs are becoming important for monitoring the progress of cancer therapy and for evaluating new therapeutic approaches. Here, we characterize and compare the specific markers that have been found to be present on stem cells, cancer cells and CSCs in selected tissues (colon, breast, liver, pancreas and prostate). We then discuss future directions of this intriguing new research field in the context of new diagnostic and therapeutic opportunities.

Place, publisher, year, edition, pages
Elsevier, 2008. Vol. 14, no 10, 450-460 p.
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) Biochemistry and Molecular Biology Cell Biology
Identifiers
URN: urn:nbn:se:liu:diva-86923DOI: 10.1016/j.molmed.2008.08.003ISI: 000260553100004OAI: oai:DiVA.org:liu-86923DiVA: diva2:583288
Available from: 2013-01-07 Created: 2013-01-07 Last updated: 2017-12-06

Open Access in DiVA

fulltext(597 kB)8166 downloads
File information
File name FULLTEXT01.pdfFile size 597 kBChecksum SHA-512
6180e80b6be73bd42cd81ffed7b644ecc4f9d8a400e0cc968b152f76b4da634e46de33b7d3dce49e957d1fb56f12254b0f507b690a84920a62722176eb0e661f
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Wiechec, EmiliaLos, Marek Jan

Search in DiVA

By author/editor
Wiechec, EmiliaLos, Marek Jan
In the same journal
Trends in Molecular Medicine
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)Biochemistry and Molecular BiologyCell Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 8166 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 363 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf